Search results for "Review article"

showing 10 items of 426 documents

What are the ethical dimensions in the profession of intensive care specialist?

2017

International audience; Two essential components of the profession of a medical doctor are the constant review of the patient's therapeutic project, and collaboration between healthcare professionals. The profession of intensive care unit (ICU) physician goes further in terms of responsibility, vis-à-vis the intensive treatments dispensed to the patients, and the physician's responsibilities towards the patient's family and the caregiving team, also bearing in mind that ICU care is costly in terms of human and financial resources. In this review, we address the profession of ICU physician from the perspective of the ethical questions that arise constantly, focusing on the timeframe of the r…

Intensive care unit (ICU)intensive care specialistAdvance care planningPalliative careProcess (engineering)Intensive care specialistReview Article0603 philosophy ethics and religionlaw.invention03 medical and health sciences0302 clinical medicineNursingMultidisciplinary approachlawmedicine030212 general & internal medicinebusiness.industryAbandonment (legal)[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie06 humanities and the artsGeneral Medicinemedicine.diseaseethicsIntensive care unit3. Good health[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie060301 applied ethicsMedical emergencybusinessMedical doctorAnnals of Translational Medicine
researchProduct

What are the ethical issues in relation to the role of the family in intensive care?

2017

International audience; A large proportion of patients admitted to the intensive care unit (ICU) are unable to express themselves, often due to acute illness, shock or trauma, and this precludes any communication and/or consent for care that might reflect their wishes and opinions. In such cases, the only solution for the ICU physician is to include the patient's family in the healthcare decisions. This can represent a significant burden on the family, on top of the psychological distress of the ICU environment and hospitalisation of their relatives, and many family members may suffer from anxiety, depression or symptoms of post-traumatic stress disorder (PTSD) during or after the hospitali…

Intensive care unit (ICU)medicine.medical_specialtyfamilyMEDLINEReview Articlelaw.invention03 medical and health sciences0302 clinical medicinelawIntensive careHealth careMedicine030212 general & internal medicineIntensive care medicineDepression (differential diagnoses)Ethical issuesbusiness.industrycommunicationsatisfactionPsychological distress030208 emergency & critical care medicine[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieGeneral MedicineIntensive care unitethics3. Good healthAnxiety[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusiness
researchProduct

Nonsurgical Procedures for Keratoconus Management

2017

Objectives. To describe the past 20 years’ correction modalities for keratoconus and their visual outcomes and possible complications.Methods. A review of the published literature related to the visual outcomes and possible complications in the context of keratoconus management using nonsurgical procedures for the last 20 years (glasses and contact lenses) was performed. Original articles that reported the outcome of any correction modalities of keratoconus management were reviewed.Results. The most nonsurgical procedure used on keratoconus management is the contact lens fitting. Soft contact lenses and soft toric contact lenses, rigid gas-permeable contact lenses, piggyback contact lens sy…

Keratoconusgenetic structuresPopulationLentes de contactoContext (language use)Review Articlelaw.invention03 medical and health sciences0302 clinical medicinelcsh:OphthalmologylawmedicineOptometríaIn patienteducationeducation.field_of_studyModalitiesbusiness.industrySurgical proceduresmedicine.diseaseeye diseasesContact lensLens (optics)Ophthalmologylcsh:RE1-994030221 ophthalmology & optometryOptometryOftalmologíaÓptica oftálmicasense organsbusiness030217 neurology & neurosurgery
researchProduct

Recurrent angioedema and the threat of asphyxiation.

2009

Angioedema (also known as Quincke disease) is the name given to edema lasting 1–7 days that recurs at irregular intervals. Target organs are the skin, tongue, glottis and larynx, gastrointestinal tract, and sometimes other soft organs. The clinical symptom referred to as angioedema forms part of a variety of disease entities (Box 1, Figure 1). In Germany, according to the present author’s estimate, several thousand patients suffer from one of the forms of recurrent angioedema. Cases of sudden asphyxiation are rare, but do occur every now and again (1). This review aims to draw attention to the various clinical features of recurrent angioedema and the practical steps for dealing with it, and…

Larynxmedicine.medical_specialtyDNA Mutational AnalysisReview ArticleC1-inhibitorAsphyxiaimmune system diseasesRecurrenceRisk FactorsEdemamedicineAmbulatory CareHumanscardiovascular diseasesAngioedemaskin and connective tissue diseasesPseudoallergic reactionChronic urticariabiologyAngioedemabusiness.industryfood and beveragesGeneral MedicineAirway obstructionmedicine.diseaseDermatologyAirway Obstructionmedicine.anatomical_structureImmunologyHereditary angioedemaFactor XIIbiology.proteinmedicine.symptombusinessComplement C1 Inhibitor ProteinDeutsches Arzteblatt international
researchProduct

Role of adipokines signaling in the modulation of T cells function

2013

The field that links immunity and metabolism is rapidly expanding. Apparently non-immunological disorders such as obesity and type 2 diabetes have been linked to immune dysregulation, suggesting that metabolic alterations can be induced by or be consequence of an altered self-immune tolerance. In this context, adipose tissue produces and releases a variety of pro-inflammatory and anti-inflammatory factors, termed "adipokines," which can be considered as the bridge between obesity-related exogenous factors, such as nutrition and lifestyle, and the molecular events leading to metabolic syndrome, inflammatory, and/or autoimmune conditions. In obesity, increased production of most adipokines im…

Leptinlcsh:Immunologic diseases. AllergyobesityImmunologyT cellsAdipose tissueAdipokineContext (language use)Review Articlemedicine.disease_cause03 medical and health sciences0302 clinical medicineImmune systemmedicineImmunology and Allergy030304 developmental biologyobesity.0303 health sciencesbusiness.industryLeptinLipid metabolismImmune dysregulationmedicine.disease3. Good health030220 oncology & carcinogenesisadipocytokinesImmunologyAdiponectinMetabolic syndromebusinesslcsh:RC581-607Frontiers in Immunology
researchProduct

Metabolic Factors and Chronic Hepatitis C: A Complex Interplay

2013

In the last years, several lines of evidence showed how metabolic factors may influence the natural history of patients with chronic hepatitis C. Chronic HCV infection is able to perturb the metabolic homeostasis of the host, in a context of complex interactions where pre-existent metabolic status and genetic background play an important role, allowing us to state that HCV infection is a systemic disease. In this review, we discuss the most recent lines of evidence on the main metabolic factors that are known to be associated with CHC, namely, insulin resistance/type 2 diabetes, steatosis, visceral obesity, atherosclerosis, vitamin D, menopause, fructose and coffee intake, lipoproteins, met…

Liver CirrhosisSystemic diseaselcsh:MedicineContext (language use)Review ArticleType 2 diabetesBiologyGeneral Biochemistry Genetics and Molecular BiologyInsulin resistanceRisk FactorsmedicineVitamin D and neurologyHumansHCV STEATOSIS METABOLIC SYNDROMEGeneral Immunology and Microbiologylcsh:RGeneral MedicineHepatitis C Chronicmedicine.diseaseMenopauseDiabetes Mellitus Type 2LiverMethylenetetrahydrofolate reductaseImmunologyDisease Progressionbiology.proteinInsulin ResistanceSteatosis
researchProduct

Liver injury, SARS‐COV‐2 infection and COVID‐19: What physicians should really know?

2021

Abstract Background & Aims Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is responsible for coronavirus disease 2019 (COVID‐19), which in males, especially in advanced age, can sometimes evolve into acute respiratory distress syndrome. In addition, mild to moderate alterations in liver function tests (LFTs) have been reported in the worst affected patients. Our review aims to analyse data on the incidence and prognostic value of LFT alterations, the underlying mechanisms and the management of pre‐existing liver disease in COVID‐19 affected patients. Methods We searched available literature through online PubMed database using terms as “SARS‐CoV‐2,” “Liver damage,” “Liver Func…

Liver injurymedicine.medical_specialtyCirrhosismedicine.diagnostic_testbusiness.industryMortality rateIncidence (epidemiology)Review Articlemedicine.diseaseSARS‐CoV‐2PneumoniaLiver diseaseCOVID‐19Internal medicinemedicineLiver Function tests (LTFs)businessLiver function testsliver injuryCohort studyGastroHep
researchProduct

ST segment elevations: Always a marker of acute myocardial infarction?

2013

AbstractChest pain is one of the chief presenting complaints among patients attending Emergency department. The diagnosis of acute myocardial infarction may be a challenge. Various tools such as anamnesis, blood sample (with evaluation of markers of myocardial necrosis), ultrasound techniques and coronary computed tomography could be useful. However, the interpretation of electrocardiograms of these patients may be a real concern. The earliest manifestations of myocardial ischemia typically interest T waves and ST segment. Despite the high sensitivity, ST segment deviation has however poor specificity since it may be observed in many other cardiac and non-cardiac conditions. Therefore, when…

Lung Diseasesmedicine.medical_specialtyBenign early repolarizationRD1-811Gastrointestinal DiseasesChest pain Differential diagnosis ECG Myocardial infarction ST segmentReview ArticleChest painDiagnosis DifferentialChest painElectrocardiographyCardiac Conduction System DiseaseHeart Conduction SystemInternal medicineT wavemedicineHumansST segmentDiseases of the circulatory (Cardiovascular) systemMyocardial infarctionBrugada SyndromeAnamnesisbusiness.industryECGElectrocardiography in myocardial infarctionArrhythmias CardiacEmergency departmentmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMyocardial infarctionCardiovascular DiseasesST segmentRC666-701CardiologyDifferential diagnosisSurgerymedicine.symptombusinessCardiology and Cardiovascular MedicineIndian Heart Journal
researchProduct

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use…

2013

This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in…

MAPK/ERK pathwayHealth Toxicology and MutagenesisNF-KAPPA-BReceptors Cytoplasmic and NuclearReview ArticlePharmacologyToxicologyToxicogeneticsNon-parenchymal cells0302 clinical medicineInduced pluripotent stem cellANION-TRANSPORTING POLYPEPTIDECONSTITUTIVE ANDROSTANE RECEPTOR0303 health sciencesGeneral Medicine3. Good healthCell biologymedicine.anatomical_structureLiver030220 oncology & carcinogenesisHepatocyte[SDV.TOX]Life Sciences [q-bio]/ToxicologyInactivation MetabolicClearanceDILIStem cellPLURIPOTENT STEM-CELLSFARNESOID-X-RECEPTORSignal TransductionMechanisms of gene regulationARYL-HYDROCARBON RECEPTORCell signalingPharmacology and ToxicologyHEPATIC STELLATE CELLSBiology03 medical and health sciencesOrgan Culture TechniquesIn vivoCulture TechniquesToxicity TestsmedicineMathematical modeling.AnimalsHumansLiver X receptorDRUG-DRUG INTERACTIONS030304 developmental biologyCryopreservation[INFO.INFO-MO]Computer Science [cs]/Modeling and Simulation3D ModelsCoculture TechniquesHigh-Throughput Screening AssaysSALT EXPORT PUMPGene Expression RegulationHepatic stellate cellHepatocytes[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyPRIMARY RAT HEPATOCYTESMathematical modeling
researchProduct

Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants

2020

AbstractAs a result of the successful completion of their respective phase III studies compared with vitamin K antagonists (VKAs), four direct oral anticoagulants (DOACs) have been approved for the treatment and secondary prevention of venous thromboembolism (VTE). These DOACs—apixaban, dabigatran, edoxaban, and rivaroxaban—have subsequently seen a steady uptake among clinicians since their approval. Despite the suitability of DOACs for a broad range of patients, they are not appropriate in certain situations, whereas in others they require additional considerations such as dose reductions. Subanalyses of phase III trials and studies on specific VTE patient populations have been conducted t…

Male0301 basic medicineComorbidity030204 cardiovascular system & hematologychemistry.chemical_compound0302 clinical medicinePregnancyEdoxabanNeoplasmsSecondary PreventionChildspecial populationsAge FactorsVenous ThromboembolismHematologyMiddle AgedTreatment OutcomePractice Guidelines as TopicFemaleKidney Diseasesmedicine.drugAdultmedicine.medical_specialtyMEDLINEHemorrhagecomorbiditiesdirect oral anticoagulantsDabigatran03 medical and health sciencesmedicineHumansLactationDosingIntensive care medicineAgedDose-Response Relationship Drugbusiness.industryPatient SelectionPregnancy Complications HematologicContraindications DrugAnticoagulantsmedicine.diseaseComorbidityReview articleClinical trial030104 developmental biologyClinical Trials Phase III as TopicchemistrybusinessVenous thromboembolismFactor Xa InhibitorsThrombosis and Haemostasis
researchProduct